Showing results (1061-1070 of 1,175) with videos related to

Sort By:
Pageof 118
Trends in Genetics : TIG|December 6, 2025
Autism genetics: perspectives, discourse, and community engagementBenjamin E Life, Taylor R Thomas, , et al.
MMWR. Morbidity and Mortality Weekly Report|May 14, 2026
Knowledge, Attitudes, and Practices Regarding Avian Influenza Among Owners of Backyard Flocks - United States, July-December 2025Melissa A Rolfes, Leah Bauck, Beth A Lipton, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypesChantel D Sloan, Li Shen, John D West, et al.
Cancer Immunology Research|May 25, 2022
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor EffectsRomain Mary, Fanny Chalmin, Théo Accogli, et al.
JAMA Oncology|January 2, 2025
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical TrialStephen Daw, Peter D Cole, Bradford S Hoppe, et al.
Blood|December 23, 2022
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adultsPaul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc, et al.
Frontiers in Immunology|October 30, 2020
HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and MacrophagesMohammed Ghiboub, Jing Zhao, Andrew Y F Li Yim, et al.
Clinical Colorectal Cancer|November 8, 2011
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancerLeonard Saltz, Suprith Badarinath, Shaker Dakhil, et al.
Pediatric Blood & Cancer|July 17, 2019
Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology GroupAdam J Esbenshade, Lisa S Kahalley, Reto Baertschiger, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exerciseKatherine C Horton, Alvaro Schwalb, Martin J Harker, et al.
Pageof 118